Literature DB >> 20374511

LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor.

N Kitkumthorn1, A Mutirangura.   

Abstract

OBJECTIVE: Global hypomethylation is a common epigenetic event in cancer. Keratocystic odontogenic tumor (KCOT) and ameloblastoma are different tumors but posses the same tissue in origin. Here, we investigated long interspersed nuclear element-1 (LINE-1 or L1) methylation status between ameloblastoma and KCOT.
MATERIALS AND METHODS: We studied the methylation levels of the long interspersed nucleotide element-1 (LINE-1) in ameloblastoma and KCOT. After collecting ameloblastoma cells and epithelium lining cells of KCOT by laser capture microdissection from paraffin embedded tissue, combined bisulfite restriction analysis of LINE-1 (COBRALINE-1) was performed to measure LINE-1 methylation levels.
RESULTS: The LINE-1 methylation level in KCOT (53.16 +/- 12.03%) was higher than that in ameloblastoma (36.90 +/- 16.52%), with a statistical significance of P = 0.001. The ranges of LINE-1 methylation of both lesions were not associated with either age or sex.
CONCLUSION: We found LINE-1 hypomethylation levels between ameloblastoma and KCOT are different. Therefore, global methylations between these tumors are processed differently.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20374511     DOI: 10.1111/j.1601-0825.2009.01640.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  6 in total

Review 1.  Epigenetic alterations in ameloblastomas: A literature review.

Authors:  Erison-Santana Santos; Carla-Isabelly Rodrigues-Fernandes; Joab-Cabral Cabral; Felipe-Paiva Fonseca; Adriana-Franco-Paes Leme
Journal:  J Clin Exp Dent       Date:  2021-03-01

2.  Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications.

Authors:  Nakarin Kitkumthorn; Apiwat Mutirangura
Journal:  Clin Epigenetics       Date:  2011-04-10       Impact factor: 6.551

3.  Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma.

Authors:  Lucyana Conceição Farias; Carolina Cavaliéri Gomes; Marcela Carolina Rodrigues; Wagner Henriques de Castro; Júlio César Tanos Lacerda; Efigênia Ferreira E Ferreira; Ricardo Santiago Gomez
Journal:  BMC Clin Pathol       Date:  2012-08-06

4.  LINE-1 and Alu hypomethylation in mucoepidermoid carcinoma.

Authors:  Porntipa Sirivanichsuntorn; Somboon Keelawat; Kittipong Danuthai; Apiwat Mutirangura; Keskanya Subbalekha; Nakarin Kitkumthorn
Journal:  BMC Clin Pathol       Date:  2013-03-19

5.  MicroRNAs expression profile in solid and unicystic ameloblastomas.

Authors:  A Setién-Olarra; X Marichalar-Mendia; N G Bediaga; P Aguirre-Echebarria; J M Aguirre-Urizar; A Mosqueda-Taylor
Journal:  PLoS One       Date:  2017-10-20       Impact factor: 3.240

6.  Expression of DNMTs and H3K9ac in Ameloblastoma and Ameloblastic Carcinoma.

Authors:  Gleyson Kleber do Amaral-Silva; Thayná Melo de Lima Morais; Vivian Petersen Wagner; Manoela Domingues Martins; Eduardo Rodrigues Fregnani; Fernando Augusto Soares; André Caroli Rocha; Helder Rabelo Pontes; Alan Roger Santos-Silva; Pablo Agustin Vargas
Journal:  Front Oral Health       Date:  2021-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.